Detalhe da pesquisa
1.
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma.
Mod Pathol
; 36(5): 100154, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36925069
2.
High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.
Histopathology
; 81(6): 732-741, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35993150
3.
Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.
Pediatr Blood Cancer
; 69(1): e29316, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34546642
4.
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
BMC Cancer
; 21(1): 920, 2021 Aug 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34391399
5.
ISH-based HER2 diagnostics.
Pathologe
; 42(Suppl 1): 62-68, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33346874
6.
[Quality assurance in dMMR and MSI diagnostics]. / Qualitätssicherung in der dMMR- und MSI-Diagnostik.
Pathologe
; 42(4): 405-413, 2021 Jul.
Artigo
Alemão
| MEDLINE | ID: mdl-33835236
7.
MSI testing : What's new? What should be considered?
Pathologe
; 42(Suppl 1): 110-118, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34477921
8.
[MSI testing : What is new? What should be considered? German version]. / MSI-Testung : Was ist neu? Was ist zu beachten?
Pathologe
; 42(4): 414-423, 2021 Jul.
Artigo
Alemão
| MEDLINE | ID: mdl-34043067
9.
[ISH-based HER2 diagnostics]. / ISH-basierte HER2-Diagnostik.
Pathologe
; 41(6): 606-613, 2020 Nov.
Artigo
Alemão
| MEDLINE | ID: mdl-33001242
10.
Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy.
Cancer
; 130(9): 1711-1712, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38430458
11.
Human epidermal growth factor receptor 2-positive digestive tumors.
Curr Opin Oncol
; 31(4): 354-361, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31170116
12.
Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms.
Mod Pathol
; 31(11): 1630-1644, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29946185
13.
Erratum to High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma [Modern Pathology 36(5) (2023) 100154].
Mod Pathol
; 36(7): 100238, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37327723
14.
Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer.
Histopathology
; 72(3): 449-459, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28851100
15.
Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.
Mod Pathol
; 30(2): 217-226, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27767099
16.
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas.
Mod Pathol
; 29(10): 1165-72, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27389313
17.
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
BMC Cancer
; 21(1): 1024, 2021 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34526003
18.
Impact of updated HER2 testing guidelines in breast cancer--re-evaluation of HERA trial fluorescence in situ hybridization data.
Mod Pathol
; 28(12): 1528-34, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26403781
19.
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.
Gastric Cancer
; 18(3): 476-84, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25038874
20.
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity.
Mod Pathol
; 27(1): 4-18, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23807776